Board Observer Rights Letter

BOARD OBSERVER RIGHTS LETTER

Date: [__/__/____]

To: [INVESTOR LEGAL NAME]
[Investor Address Line 1]
[Investor Address Line 2]

From: [COMPANY LEGAL NAME], a [State of Incorporation] [corporation/limited liability company] (the "Company")

Re: Board Observer Rights

1. Grant of Observer Right

Reference is made to that certain [Series [__] Preferred Stock Purchase Agreement / Investors' Rights Agreement / Note Purchase Agreement / Loan and Security Agreement] dated as of [__/__/____] (the "Investment Agreement") by and between the Company and [INVESTOR LEGAL NAME] ("Investor").

Subject to the terms and conditions of this letter agreement (this "Letter"), the Company hereby grants to Investor the right to designate one (1) natural person (the "Observer") to attend all meetings of the Company's Board of Directors (the "Board") in a non-voting observer capacity.

Initial Observer: [OBSERVER FULL NAME]

Investor may change the designated Observer from time to time upon written notice to the Company, subject to Section 7 (Qualifications and Removal).

2. Attendance Rights

☐ Board Meetings. The Observer shall be entitled to attend, in a non-voting observer capacity, all regular and special meetings of the Board, whether in person, by telephone, by video conference, or by other electronic means.

☐ Committee Meetings. The Observer [shall / shall not] be entitled to attend meetings of the following committees: [________________________________].

☐ Executive Sessions. The Board may, in its sole discretion, exclude the Observer from any executive session or any portion of a meeting.

3. Notice and Materials

The Company shall provide to the Observer:

(a) Notice of each Board meeting concurrently with, and by the same means as, notice is provided to the members of the Board;

(b) Copies of all materials (including agendas, board decks, financial statements, management reports, consent forms, and written consents in lieu of meeting) distributed to Board members, concurrently with, and by the same means as, such materials are distributed to directors; and

(c) Minutes of each Board meeting promptly after they are approved.

The Company shall not be required to provide materials or access to information that, in the reasonable good-faith judgment of the Board, would:

☐ Adversely affect the attorney-client privilege between the Company and its counsel;
☐ Result in disclosure of trade secrets or proprietary know-how to a competitor;
☐ Create an actual or potential conflict of interest between the Company and the Investor; or
☐ Violate applicable law, regulation, contract, or court/regulatory order.

4. Confidentiality Obligations

The Observer and Investor shall hold in strict confidence, and shall not use or disclose to any third party, any information (whether written or oral, and whether or not marked "confidential") received in connection with the Observer's attendance at Board meetings or otherwise made available to the Observer or Investor under this Letter ("Confidential Information"), except:

(a) to Investor's partners, members, officers, directors, employees, attorneys, accountants, and other professional advisors who have a need to know such information and who are bound by confidentiality obligations at least as protective as those set forth herein;

(b) as required by applicable law, regulation, or legal process, provided that Investor shall (to the extent legally permitted) give the Company prompt prior written notice and reasonable cooperation to seek a protective order; and

(c) with the prior written consent of the Company.

Exclusions. Confidential Information does not include information that (i) is or becomes publicly available through no breach of this Letter, (ii) was rightfully in Investor's possession without confidentiality obligation prior to disclosure by the Company, (iii) is rightfully received from a third party without confidentiality obligation, or (iv) is independently developed without use of or reference to Confidential Information.

Duration. The confidentiality obligations in this Section 4 shall survive termination of observer rights for a period of [three (3) / five (5)] years, except that trade secrets shall be protected for so long as they remain trade secrets under applicable law.

5. Securities Laws; Insider Trading

The Observer acknowledges that Confidential Information may constitute material non-public information within the meaning of the United States securities laws, including Rule 10b-5 promulgated under the Securities Exchange Act of 1934. The Observer and Investor agree that neither shall, while in possession of such material non-public information:

☐ Purchase or sell securities of the Company or any of its affiliates;
☐ Tip, recommend, or share such information with any person who may trade on it; or
☐ Engage in any other transaction that would violate applicable securities laws.

The Company may adopt an insider trading policy and require the Observer to acknowledge and comply with such policy and any related trading blackout windows.

6. No Fiduciary Duties; No Indemnification

The Observer is not a director or officer of the Company and shall not owe any fiduciary duties to the Company or its stockholders by virtue of attendance at Board meetings. The Observer shall have no right to vote on any matter before the Board and shall not be counted for purposes of determining a quorum.

Indemnification. The Company [shall / shall not] indemnify the Observer on the same terms as directors under the Company's [Certificate of Incorporation / Bylaws / indemnification agreements].

D&O Insurance. The Company [shall / shall not] include the Observer as an insured under the Company's directors' and officers' liability insurance policy to the extent such coverage is available at commercially reasonable rates.

7. Qualifications and Removal

The Company may require that any Observer:

(a) Not be a director, officer, employee, agent, or consultant of a Company Competitor (as defined below);
(b) Execute a confidentiality agreement in a form reasonably acceptable to the Company (which may incorporate terms of this Letter by reference);
(c) Comply with the Company's insider trading policy and code of conduct as applicable to directors; and
(d) Not be subject to any "bad actor" disqualifying event under Rule 506(d) of Regulation D or any similar federal or state law.

"Company Competitor" means [________________________________].

The Company may exclude or remove any Observer who fails to satisfy these qualifications, upon which Investor shall have a reasonable opportunity (not less than [thirty (30)] days) to designate a replacement.

8. Expenses

The Company [shall / shall not] reimburse the Observer for reasonable, documented out-of-pocket expenses incurred in connection with attendance at Board meetings, on the same terms as apply to directors.

9. Termination

Observer rights granted under this Letter shall automatically terminate upon the earliest to occur of:

(a) The date on which Investor and its affiliates collectively hold less than [____]% of the outstanding [Series [__] Preferred Stock / capital stock on an as-converted basis / principal amount of the Notes];

(b) The closing of a Deemed Liquidation Event (as defined in the Company's Certificate of Incorporation) or a firm-commitment underwritten initial public offering of the Company's common stock;

(c) A material breach by the Observer or Investor of Section 4 (Confidentiality) or Section 5 (Securities Laws) that, if curable, is not cured within [ten (10)] days of written notice;

(d) The Observer or Investor becomes a Company Competitor; or

(e) Written agreement of the Company and Investor.

Sections 4 (Confidentiality), 5 (Securities Laws), 10 (Miscellaneous), and any accrued rights and obligations shall survive termination.

10. Miscellaneous

☐ Governing Law. This Letter shall be governed by the laws of the State of [Delaware / ____], without regard to conflicts-of-law principles.

☐ Dispute Resolution. Any dispute arising under this Letter shall be resolved [in the state or federal courts located in [____] / by binding arbitration under the [JAMS / AAA] Comprehensive Arbitration Rules in [____]].

☐ Assignment. Investor may assign its rights under this Letter only to an affiliate or successor fund that (i) is not a Company Competitor and (ii) agrees in writing to be bound by this Letter. No other assignment shall be effective without the Company's prior written consent.

☐ Entire Agreement. This Letter, together with the Investment Agreement, constitutes the entire agreement between the parties with respect to observer rights and supersedes all prior understandings.

☐ Amendment. This Letter may be amended only by a written instrument signed by both parties.

☐ Counterparts; Electronic Signatures. This Letter may be executed in counterparts, including by electronic signature (DocuSign, PDF, or similar), each of which shall be deemed an original.

☐ No Third-Party Beneficiaries. Except for the Observer (who is an intended third-party beneficiary of Sections 2, 3, 6, and 8), this Letter confers no rights on any person not a party hereto.

☐ Notices. All notices shall be in writing and delivered to the addresses set forth above (or such other address as a party may designate by notice).

Signatures

COMPANY:

[COMPANY LEGAL NAME]

By: [________________________________]
Name: [________________________________]
Title: [________________________________]
Date: [__/__/____]

INVESTOR:

[INVESTOR LEGAL NAME]

By: [________________________________]
Name: [________________________________]
Title: [________________________________]
Date: [__/__/____]

ACKNOWLEDGED AND AGREED BY OBSERVER:

By my signature below, I acknowledge that I have read this Letter and agree to be bound by the confidentiality, securities-law, and qualification provisions applicable to the Observer.

[________________________________]
[OBSERVER FULL NAME], Observer
Date: [__/__/____]

Drafting Notes

• Non-fiduciary status is the key legal point. Unlike directors, observers are not subject to fiduciary duties as a matter of Delaware (or most state) corporate law. Confidentiality and trading restrictions therefore must be imposed by contract — this Letter is the contract.
• Privilege protection. If the Observer regularly sits in on privileged discussions, consider a separate common-interest / joint-defense agreement, or exclude the Observer from privileged portions of meetings.
• Rule 506(d) bad-actor diligence is required if the Company has raised or will raise capital in a Rule 506 offering; the Observer's status may be imputed to the Company in some circumstances.
• SBIC and regulated investors. If the Investor is an SBIC, BDC, or registered investment adviser, additional restrictions may apply — verify with Investor's counsel.
• Drop-down threshold (Section 9(a)). Typical range: observer right drops when Investor holds less than 25% of the original investment (for preferred) or when the notes/loan are repaid in full (for debt).
• Foreign investors / CFIUS. Observer rights that include access to sensitive U.S. technology or personal data can trigger CFIUS covered-investment review under 31 C.F.R. Part 800. Diligence the Investor's ownership chain.

Sources and References

• Harvard Law School Forum on Corporate Governance, The Board Observer: Considerations and Limitations (July 2, 2025): https://corpgov.law.harvard.edu/2025/07/02/the-board-observer-considerations-and-limitations/
• SEC EDGAR, sample Board Observer and Confidentiality Agreement (Nov. 1, 2021): https://www.sec.gov/Archives/edgar/data/1509589/000119312521318493/d205905dex108.htm
• Linden Law Partners, Understanding and Structuring Board Observer Rights: https://lindenlawpartners.com/understanding-and-structuring-board-observer-rights/
• Thomson Reuters Practical Law, Board Observer: https://uk.practicallaw.thomsonreuters.com/2-501-5854
• Delaware General Corporation Law § 141 (board of directors): https://delcode.delaware.gov/title8/c001/sc04/
• 17 C.F.R. § 240.10b-5 (Rule 10b-5): https://www.ecfr.gov/current/title-17/chapter-II/part-240
• 17 C.F.R. § 230.506 (Regulation D, Rule 506 — bad actor disqualification): https://www.ecfr.gov/current/title-17/chapter-II/part-230/subject-group-ECFR6e651a4c86c0174/section-230.506
• 31 C.F.R. Part 800 (CFIUS covered investments): https://www.ecfr.gov/current/title-31/subtitle-B/chapter-VIII/part-800

This template is provided for informational purposes only and does not constitute legal advice. Have it reviewed by qualified counsel in your jurisdiction before use.